No major association of ApoE genotype with disease characteristics and MRI findings in multiple sclerosis (Q47276347)

13 January 2018

title

No major association of ApoE genotype with disease characteristics and MRI findings in multiple sclerosis (English)

1 reference

13 January 2018

author name string

J N P Zwemmer

1

1 reference

13 January 2018

T van Veen

2

1 reference

13 January 2018

L van Winsen

3

1 reference

13 January 2018

G J van Kamp

4

1 reference

13 January 2018

F Barkhof

5

1 reference

13 January 2018

C H Polman

6

1 reference

13 January 2018

B M J Uitdehaag

7

1 reference

13 January 2018

publication date

1 June 2004

1 reference

13 January 2018

Multiple Sclerosis Journal

published in

1 reference

13 January 2018

volume

10

1 reference

13 January 2018

issue

3

1 reference

13 January 2018

page(s)

272-277

1 reference

13 January 2018

Differential effects of apolipoproteins E3 and E4 on neuronal growth in vitro

cites work

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS1010OA

A role for apolipoprotein E, apolipoprotein A-I, and low density lipoprotein receptors in cholesterol transport during regeneration and remyelination of the rat sciatic nerve

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS1010OA

Apolipoprotein E and the CNS response to injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS1010OA

A genome screen in multiple sclerosis reveals susceptibility loci on chromosome 6p21 and 17q22

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS1010OA

Genomewide scan of multiple sclerosis in Finnish multiplex families

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS1010OA

A full genome search in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS1010OA

Apolipoprotein E allele-specific antioxidant activity and effects on cytotoxicity by oxidative insults and beta-amyloid peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS1010OA

Apo E genotypes in multiple sclerosis, Parkinson's disease, schwannomas and late-onset Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS1010OA

Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS1010OA

Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS1010OA

Apoliprotein E and multiple sclerosis: impact of the epsilon-4 allele on susceptibility, clinical type and progression rate

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS1010OA

APOE genotype is a major predictor of long-term progression of disability in MS

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS1010OA

Apolipoprotein E epsilon 4 is associated with rapid progression of multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS1010OA

Apolipoprotein E (APOE) phenotype and APOE concentrations in multiple sclerosis and acute herpes zoster.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS1010OA

Association of polymorphisms in the apolipoprotein E region with susceptibility to and progression of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS1010OA

Involvement of apolipoprotein E in multiple sclerosis: absence of remyelination associated with possession of the APOE epsilon2 allele

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS1010OA

The role of magnetic resonance techniques in understanding and managing multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS1010OA

Apolipoprotein E genotype related differences in brain lesions of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS1010OA

Progressive cerebral atrophy in multiple sclerosis. A serial MRI study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS1010OA

A longitudinal study of brain atrophy in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG).

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS1010OA

Disease severity in Danish multiple sclerosis patients evaluated by MRI and three genetic markers (HLA-DRB1*1501, CCR5 deletion mutation, apolipoprotein E).

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS1010OA

New diagnostic criteria for multiple sclerosis: guidelines for research protocols

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS1010OA

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS1010OA

Optimizing the association between disability and biological markers in MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS1010OA

Association of apolipoprotein E polymorphism to clinical heterogeneity of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS1010OA

10.1191/1352458504MS1010OA

21 January 2018

Identifiers

DOI

1 reference

13 January 2018

1 reference

13 January 2018